To amend the Public Health Service Act to establish a grant program for providing services to individuals experiencing gambling addiction.
Summary
HR7875 (POINTS Act of 2026) is a bill in the earliest legislative stage authorizing a grant program for gambling addiction services, but it has no appropriated funding and zero near-term market impact. The bill was introduced on 2026-03-09 and referred to committee with no further action. No publicly traded company is directly or materially affected at this stage.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.HR7875 is at the earliest legislative stage with zero appropriated funding and no specified authorization amount.
- 2.No publicly traded company is named or directly affected by this bill in its current form.
- 3.Investors should monitor for committee markup or a Senate companion bill before considering any sector impact.
Market Implications
No near-term market implications. This bill is procedural and has not moved since introduction over a month ago. No tickers are actionable based on this legislation at this time.
Full Analysis
What happened: Rep. Houchin (R-IN) introduced HR7875, the POINTS Act of 2026, on March 9, 2026, which would amend the Public Health Service Act to establish a competitive grant program for states, Tribes, and Tribal organizations to provide prevention, screening, treatment, and support services for gambling addiction. The bill has three cosponsors and was referred to the House Committee on Energy and Commerce.
Current status: The bill is in the earliest legislative stage — introduced and referred to committee. It has not been marked up, reported out, or voted on. No companion bill exists in the Senate. The legislative path is long and uncertain: it must pass committee, pass the House, pass the Senate, and be signed into law.
Money trail: Authorization vs Appropriation — The bill authorizes a grant program but does NOT specify any dollar amount. Section 554 describes what the program would do but does not include an authorized funding level. This means even if the bill became law, it would require a separate appropriations bill to allocate actual funds. Since no dollar amount is specified and no funding has been appropriated, the financial impact on any sector or company is effectively zero at this stage.
Winners and losers: At this procedural stage, there are no identifiable winners or losers among publicly traded companies. If the bill were to advance, potential beneficiaries could include behavioral health providers, addiction treatment centers, and telehealth platforms specializing in mental health (e.g., Talkspace ($TALK), LifeStance Health ($LFST)), but any impact would be years away and dependent on future appropriations. Currently, the bill does not name any private entity or create any mandate on for-profit companies.
Timeline: The bill has had zero legislative actions since introduction on March 9, 2026. There is no scheduled markup, no Senate companion, and no indication of near-term movement. For retail investors, this bill is not actionable.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
ADAPT Act
THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND): $1.8B Department of State Federal Award
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →